Barclays Reiterates Overweight Rating on AstraZeneca (AZN:LN) (AZN)
Barclays analyst Emily Field ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)